Vaccinex Inc (VCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,863 | -29,518 | -18,759 | -13,943 | N/A |
| Depreciation Amortization | 205 | 431 | 1,423 | 1,744 | N/A |
| Accounts receivable | -260 | -522 | -13 | -85 | N/A |
| Accounts payable and accrued liabilities | 725 | 421 | -555 | 407 | N/A |
| Other Working Capital | 496 | 1,624 | -627 | 1,654 | N/A |
| Other Operating Activity | -18 | 2,288 | -2,856 | -9,497 | 0 |
| Operating Cash Flow | $-30,715 | $-25,276 | $-21,387 | $-19,720 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -78 | -235 | -68 | -793 | N/A |
| Purchase Of Investment | N/A | -20,756 | N/A | N/A | N/A |
| Sale Of Investment | 14,151 | 6,750 | N/A | N/A | N/A |
| Investing Cash Flow | $14,073 | $-14,241 | $-68 | $-793 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 9,977 | 6,478 | N/A |
| Debt Repayment | N/A | -5,500 | -6,000 | -800 | N/A |
| Common Stock Issued | 13,800 | 37,130 | 15 | N/A | N/A |
| Other Financing Activity | 0 | 9,325 | 19,982 | 10,679 | 0 |
| Financing Cash Flow | $13,800 | $40,955 | $23,974 | $16,357 | $N/A |
| Beginning Cash Position | 5,618 | 4,180 | 1,661 | 5,817 | N/A |
| End Cash Position | 2,776 | 5,618 | 4,180 | 1,661 | N/A |
| Net Cash Flow | $-2,842 | $1,438 | $2,519 | $-4,156 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,715 | -25,276 | -21,387 | -19,720 | N/A |
| Capital Expenditure | -78 | -235 | -68 | -793 | N/A |
| Free Cash Flow | -30,793 | -25,511 | -21,455 | -20,513 | 0 |